HomeCompareBRMK vs MRK

BRMK vs MRK: Dividend Comparison 2026

BRMK yields 12.24% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BRMK wins by $1717140.28M in total portfolio value
10 years
BRMK
BRMK
● Live price
12.24%
Share price
$4.82
Annual div
$0.59
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1717140.34M
Annual income
$1,690,607,982,980.17
Full BRMK calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — BRMK vs MRK

📍 BRMK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBRMKMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BRMK + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BRMK pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRMK
Annual income on $10K today (after 15% tax)
$1,040.46/yr
After 10yr DRIP, annual income (after tax)
$1,437,016,785,533.14/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, BRMK beats the other by $1,437,016,776,936.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRMK + MRK for your $10,000?

BRMK: 50%MRK: 50%
100% MRK50/50100% BRMK
Portfolio after 10yr
$858570.20M
Annual income
$845,303,996,546.98/yr
Blended yield
98.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BRMK
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Price Target
$6.13
+27.2% upside vs current
Range: $3.75 — $8.50
Altman Z
3.5
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRMK buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBRMKMRK
Forward yield12.24%2.81%
Annual dividend / share$0.59$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$1717140.34M$57.7K
Annual income after 10y$1,690,607,982,980.17$10,113.78
Total dividends collected$1715355.85M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$6.13$128.54

Year-by-year: BRMK vs MRK ($10,000, DRIP)

YearBRMK PortfolioBRMK Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,148$2,448.13$11,213$373.04+$1.9KBRMK
2$20,085$6,016.52$12,667$512.06+$7.4KBRMK
3$38,670$17,179.07$14,439$708.14+$24.2KBRMK
4$103,200$61,822.75$16,640$988.16+$86.6KBRMK
5$418,812$308,388.55$19,432$1,394.07+$399.4KBRMK
6$2,787,426$2,339,297.21$23,057$1,992.90+$2.76MBRMK
7$32,084,066$29,101,519.66$27,889$2,894.79+$32.06MBRMK
8$660,435,990$626,106,039.49$34,518$4,286.29+$660.40MBRMK
9$24,796,591,328$24,089,924,818.86$43,912$6,494.35+$24796.55MBRMK
10$1,717,140,335,701$1,690,607,982,980.17$57,714$10,113.78+$1717140.28MBRMK

BRMK vs MRK: Complete Analysis 2026

BRMKStock

Broadmark Realty Capital Inc. operates as a commercial real estate finance company in the United States. It engages in underwriting, funding, servicing, and managing a portfolio of short-term trust loans to fund the construction and development, or investment in residential or commercial properties. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was founded in 2010 and is headquartered in Seattle, Washington.

Full BRMK Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BRMK vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRMK vs SCHDBRMK vs JEPIBRMK vs OBRMK vs KOBRMK vs MAINBRMK vs JNJBRMK vs ABBVBRMK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.